Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada

Key Points

• Clinical outcomes of first line treatment for advanced renal cell carcinoma vary significantly in older patients, showing notable responses to therapy.
• Among older patients receiving treatment, the response rate observed was approximately 45%, underlining the potential benefits of timely intervention.
• The analysis focused on real-world management of advanced renal cell carcinoma, comparing treatment approaches across various healthcare settings in Canada.
• Findings highlight the importance of tailored approaches for older patients, advocating for further studies on the effectiveness of specific treatment protocols.